Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes
IDH-wildtype GBs without contrast enhancement are often diagnosed based on molecular criteria due to less frequent histopathological hallmarks and are associated with prolonged OS.
Authors
- Gianluca Brugnara (ORCID: https://orcid.org/0000-0003-2461-1407)
- Martin Bendszus (ORCID: https://orcid.org/0000-0002-9094-6769)
- Philipp Kickingereder (ORCID: https://orcid.org/0000-0002-6224-0064)
- Rouzbeh Banan (ORCID: https://orcid.org/0000-0002-9999-576X)
- Martha Foltyn‐Dumitru (ORCID: https://orcid.org/0009-0005-2925-9176)
- Marianne Schell (ORCID: https://orcid.org/0000-0002-9754-1350)
- Felix Sahm (ORCID: https://orcid.org/0000-0001-5441-1962)
- Mustafa Ahmed Mahmutoglu (ORCID: https://orcid.org/0000-0002-4891-5547)
- Wolfgang Wick
- Tobias Keßler (ORCID: https://orcid.org/0000-0001-8350-7074)
Institutions
- German Cancer Research Center (DE)
- University of Basel (CH)
- Heidelberg University (DE)
- University Hospital Bonn (DE)
- University Hospital Heidelberg (DE)
- University Hospital of Basel (CH)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1093/neuonc/noaf070
- Citations
- 6
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 9.75